{"id":"NCT00623103","sponsor":"Novartis","briefTitle":"Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)","officialTitle":"A 76-week Prospective, Open-label, Multicenter Study to Evaluate the Long-term Effect of Rivastigmine Capsule and Transdermal Patch on Worsening of the Underlying Motor Symptoms of PD in Patients With Mild to Moderately Severe Dementia Associated With Parkinson's Disease (PDD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2010-11","completion":null,"firstPosted":"2008-02-25","resultsPosted":"2011-11-28","lastUpdate":"2011-11-28"},"enrollment":583,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Parkinson's Disease Dementia"],"interventions":[{"type":"DRUG","name":"Rivastigmine capsule","otherNames":["Exelon®"]},{"type":"DRUG","name":"Rivastigmine transdermal patch","otherNames":["Exelon®"]}],"arms":[{"label":"Rivastigmine capsule","type":"EXPERIMENTAL"},{"label":"Rivastigmine patch","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to provide long-term safety data for rivastigmine capsule and transdermal patch treatments, in particular the effect of rivastigmine on worsening of the underlying motor symptoms of Parkinson's Disease (PD), in patients with mild to moderately severe dementia associated with PD.","primaryOutcome":{"measure":"Percentage of Participants With Adverse Events (AEs) Due, or Potentially Due, to Worsening of Parkinson Disease (PD) Motor Symptoms (Tremor, Muscle Rigidity, Bradykinesia, Fall)","timeFrame":"76 Weeks","effectByArm":[{"arm":"Rivastigmine Capsule","deltaMin":24.5,"sd":null},{"arm":"Rivastigmine Patch","deltaMin":9.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":127,"countries":["United States","Argentina","Australia","Austria","Belgium","Canada","France","Germany","Italy","Netherlands","Spain","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":87,"n":294},"commonTop":["Nausea","Fall","Parkinsonian rest tremor","Vomiting","Dizziness"]}}